|Title||Phosphate-containing polyethylene glycol polymers prevent lethal sepsis by multidrug-resistant pathogens.|
|Publication Type||Journal Article|
|Year of Publication||2014|
|Authors||A Zaborin, J. R. Defazio, M Kade, BL Kaiser, N Belogortseva, DG Camp, RD Smith, JN Adkins, SM Kim, A Alverdy, D Goldfeld, MA Firestone, JH Collier, B Jabri, M Tirrell, O Zaborina, and JC Alverdy|
|Journal||Antimicrobial agents and chemotherapy|
|Pagination||966 - 977|
Antibiotic resistance among highly pathogenic strains of bacteria and fungi is a growing concern in the face of the ability to sustain life during critical illness with advancing medical interventions. The longer patients remain critically ill, the more likely they are to become colonized by multidrug-resistant (MDR) pathogens. The human gastrointestinal tract is the primary site of colonization of many MDR pathogens and is a major source of life-threatening infections due to these microorganisms. Eradication measures to sterilize the gut are difficult if not impossible and carry the risk of further antibiotic resistance. Here, we present a strategy to contain rather than eliminate MDR pathogens by using an agent that interferes with the ability of colonizing pathogens to express virulence in response to host-derived and local environmental factors. The antivirulence agent is a phosphorylated triblock high-molecular-weight polymer (here termed Pi-PEG 15-20) that exploits the known properties of phosphate (Pi) and polyethylene glycol 15-20 (PEG 15-20) to suppress microbial virulence and protect the integrity of the intestinal epithelium. The compound is nonmicrobiocidal and appears to be highly effective when tested both in vitro and in vivo. Structure functional analyses suggest that the hydrophobic bis-aromatic moiety at the polymer center is of particular importance to the biological function of Pi-PEG 15-20, beyond its phosphate content. Animal studies demonstrate that Pi-PEG prevents mortality in mice inoculated with multiple highly virulent pathogenic organisms from hospitalized patients in association with preservation of the core microbiome.
|Short Title||Antimicrobial agents and chemotherapy|